Öner Özdemir, “Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19: Omalizumab, Urticaria, COVID-19”, Dermatol Pract Concept, vol. 14, no. 1, p. e2024078, Jan. 2024, doi: 10.5826/dpc.1401a78.